Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-282050
Filing Date
2024-12-19
Accepted
2024-12-19 16:33:00
Documents
5
Effectiveness Date
2024-12-19

Document Format Files

Seq Description Document Type Size
1 S-8 d900991ds8.htm S-8 41861
2 EX-5.1 d900991dex51.htm EX-5.1 7968
3 EX-23.2 d900991dex232.htm EX-23.2 1243
4 EX-FILING FEES d900991dexfilingfees.htm EX-FILING FEES 13421
5 GRAPHIC g900991dsp6.jpg GRAPHIC 3458
  Complete submission text file 0001193125-24-282050.txt   70480
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283944 | Film No.: 241563805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)